AstraZeneca is partnering with AI biotech insitro in a deal worth up to $1.5 billion
insitro will receive $40 million upfront and could earn up to about $1.46 billion in milestones, plus royalties
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors endpoints.news
- AstraZeneca strikes $40 million AI drug discovery deal with Insitro business-standard.com
- AstraZeneca strikes $1.5b AI drug discovery deal with Insitro techinasia.com
- AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro seekingalpha.com
- AstraZeneca strikes $40 million AI drug discovery deal with insitro channelnewsasia.com
